Ardeparin Subcutaneous and NovoLog FlexPen
Determining the interaction of Ardeparin Subcutaneous and NovoLog FlexPen and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ardeparin
Brand name: Baciguent, Probiotic Formula, Proferrin-ES
Synonyms: Ardeparin (Subcutaneous)
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ardeparin Subcutaneous-Novolog Injection
- Ardeparin Subcutaneous-NovoLog Mix 70/30
- Ardeparin Subcutaneous-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- Ardeparin Subcutaneous-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- Ardeparin Subcutaneous-NovoLog Mix 70/30 FlexPen
- Ardeparin Subcutaneous-NovoLog PenFill
- NovoLog FlexPen-Aredia
- NovoLog FlexPen-Arestin
- NovoLog FlexPen-Arestin eent
- NovoLog FlexPen-Arestin mucous membrane powder
- NovoLog FlexPen-Arformoterol
- NovoLog FlexPen-Arformoterol inhalation